The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.

The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.

Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”

The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.

“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”

Share:
More In Science
Apple Watch Alerts Woman to Blood Clot
A 29-year-old Cincinnati woman was awakened by her Apple Watch, which alerted her about an elevated heart rate, prompting her to head to a doctor who notified her of a blood clot.
Florida County Under Quarantine Over Snails
A quarantine is in place for a section of Broward county in Florida due to a rise in African land snails, which are harmful to agriculture and can eat their way through about 500 plant species.
Cheddar Reports: Montana Kids Suing State Over Climate Change 
Climate change is on trial in Montana. In a landmark case, 16 young people are suing the state over effects like smoke, heat, and drought. It's just the first in a series of cases intended to pressure lawmakers into taking action on the environment. Here with more is Cheddar News Senior Reporter Chloe Aiello.
Load More